[ Price : $8.95]
FDA expands the approved use of GlaxoSmithKlines Nucala (mepolizumab) to treat adult patients with eosinophilic granulomatosis wit...[ Price : $8.95]
Federal Register notice: FDA seeks comments on an information collection extension for Orphan Products Development; FDA Orphan Dru...[ Price : $8.95]
CDRH outlines steps it is taking to improve and expand use of patient-reported outcomes in regulatory proceedings.[ Price : $8.95]
AdvaMed recommends ways to improve CDRHs voluntary medical device manufacturing and product quality program.[ Price : $8.95]
Federal Register notice: FDA announces the Web site location where it will post two lists of guidance documents that CDRH intends ...[ Price : $8.95]
Federal Register notice: FDA makes available a guidance entitled Product Name Placement, Size, and Prominence in Promotional Label...[ Price : $8.95]
FDA releases its latest batch of Warning Letters that includes Fagron Compounding Services, RC Outsourcing and Seindni Co.[ Price : $8.95]
Federal Register notice: FDA seeks comments on an information collection extension for FDA Application for Participation in FDA Fe...